Skip to main content

HLA-DRB1,-DQA1 and -DQB1 Allele and Haplotype Frequencies in Female Patients with Early Onset Breast Cancer

Pathology & Oncology Research volume 18, pages 49–55 (2012)Cite this article

Abstract

Based on the reports, few HLA class II alleles are associated with susceptibility or protection in breast cancer. Here we investigate the association between HLA class II alleles and breast cancer in Iranian women. 100 patients with pathologically proven breast cancer who referred to Cancer Institute were randomly selected and compared with a group of 80 healthy blood donor subjects. The patients were studied in two groups, group 1 includes patients aging 40 years or younger and group 2 include patients aging over 40 years. HLA class II alleles were determined by amplification of DNA followed by HLA-typing using sequence-specific primer (SSP) for each allele. In group 1, the most frequent alleles were HLA-DQA1*0301 (P = 0.002, OR = 3.3) and HLA-DQB1*0302 (P = 0.04, OR = 2.8). In group 2, the following alleles increased significantly than those in controls including HLA-DQA1*0301 (P = 0.001, OR = 3.4) and HLA-DRB1*0301 (P = 0.04, OR = 2.3). In complete group of patients, the frequency of HLA-DQA1*0301 (P = 0.001, OR = 3.4) and HLA-DRB1*1303 (P = 0.02, OR = 2.3) increased significantly than those in control group. HLA-DQA1*0505, HLA-DQA1*0101, HLA-DRB1*1301and HLA-DRB1*0101 alleles showed negative association with breast cancer. Our findings suggest that HLA-DQA1*0301 allele is mainly associated with increased risk of breast cancer including early-onset of the disease. HLA-DQA1*0505 and HLA-DRB1*1301 are involved in protection. We conclude that specific alleles of HLA class II influence breast cancer risk.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108

    PubMed  Article  Google Scholar 

  2. Forbes JF (1997) The incidence of breast cancer: the global burden, public health considerations. Semin Oncol 24(Suppl 1):S1-20–S1-35

    Google Scholar 

  3. de Jong MM, Nolte IM, te Meerman GJ et al (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39(4):225–242

    PubMed  Article  Google Scholar 

  4. Futreal PA, Liu Q, Shattuck-Eidens D et al (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 7(266(5182)):120–122

    Article  Google Scholar 

  5. Pistillo MP, Nicolò G, Salvi S et al (2000) Biochemical analysis of HLA class I subunits expression in breast cancer tissues. Hum Immunol 61:397–407

    PubMed  CAS  Article  Google Scholar 

  6. Salih HR, Nussler V (2001) Commentary: immune escape versus tumor tolerance: how do tumors evade immune surveillance? Eur J Med Res 6:323–332

    PubMed  CAS  Google Scholar 

  7. Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991–998

    PubMed  CAS  Article  Google Scholar 

  8. Forbes SA, Trowsdale J (1997) The MHC quarterly report. Immunogenetics 50:152–159

    Article  Google Scholar 

  9. Hosono S, Kawase T, Matsuo K et al (2010) HLA-A alleles and the risk of cervical squamous cell carcinoma in Japanese women. J Epidemiol 20(4):295–301

    PubMed  Article  Google Scholar 

  10. Castro FA, Haimila K, Sareneva I et al (2009) Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population–a candidate gene approach. Int J Cancer 125(8):1851–1858

    PubMed  CAS  Article  Google Scholar 

  11. Lee HW, Hahm KB, Lee JS et al (2009) Association of the human leukocyte antigen class II alleles with chronic atrophic gastritis and gastric carcinoma in Koreans. J Dig Dis 10(4):265–271

    PubMed  Article  Google Scholar 

  12. Ishigami S, Natsugoe S, Nakajo A et al (2008) HLA-class I expression in gastric cancer. J Surg Oncol 97(7):605–608

    PubMed  CAS  Article  Google Scholar 

  13. Gamzatova Z, Villabona L, van der Zanden H et al (2007) Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer. Tissue Antigens 70(3):205–213

    PubMed  CAS  Article  Google Scholar 

  14. Gogas H, Kirkwood JM, Falk CS et al (2010) Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon. Cancer 116(18):4326–4333

    PubMed  Article  Google Scholar 

  15. Chaudhuri S, Cariappa A, Tang M et al (2000) Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc Natl Acad Sci U S A 97(21):11451–11454

    PubMed  CAS  Article  Google Scholar 

  16. Ghaderi A, Talei A, Gharesi-Fard B et al (2001) HLA-DRB1 alleles and the susceptibility of Iranian patients with breast cancer. Pathol Oncol Res 7:39–41

    PubMed  CAS  Article  Google Scholar 

  17. Lavado R, Benavides M, Villar E et al (2005) The HLA-B7 allele confers susceptibility to breast cancer in Spanish women. Immunol Lett 101(2):223–225

    PubMed  CAS  Article  Google Scholar 

  18. Cantú de León D, Pérez-Montiel D, Villavicencio V et al (2009) High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer 9:48

    PubMed  Article  Google Scholar 

  19. Miller SA, Dykes DD, Polesky HE (1989) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215–1221

    Article  Google Scholar 

  20. Amirzargar AA, Khosravi F, Dianat SS et al (2007) Association of HLA class II allele and haplotype frequencies with chronic myelogenous leukemia and age-at-onset of the disease. Pathol Oncol Res 13(1):47–51

    PubMed  CAS  Article  Google Scholar 

  21. Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225–235

    PubMed  CAS  Article  Google Scholar 

  22. Amirzargar A, Mytilineos J, Farjadian S et al (2001) Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 62:1234–1238

    PubMed  CAS  Article  Google Scholar 

  23. McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer–epidemiology, risk factors and genetics. BMJ 321(7261):624–628

    PubMed  CAS  Article  Google Scholar 

  24. Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917

    PubMed  CAS  Article  Google Scholar 

  25. World Cancer Report 2008. WHO, http://www.iarc.fr/en/publications/pdfsonline/wcr/2008/index.php (2 November 2010, date last accessed).

  26. Anderson BO, Jakesz R (2008) Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative. World J Surg 32:2578–2585

    PubMed  Article  Google Scholar 

  27. The Top 10 Causes of Death in 2004 (2008) Fact Sheet of WHO Report, World Health Organization.

  28. Harirchi I, Mousavi SM, Mohagheghi MA et al (2009) Early detection for breast cancer in Iran. Asian Pac J Cancer Prev 10(5):849–851

    PubMed  Google Scholar 

  29. Mousavi SM, Gouya MM, Ramazani R et al (2009) Cancer incidence and mortality in Iran. Ann Oncol 20:556–563

    PubMed  CAS  Article  Google Scholar 

  30. Baccar Harrath A, Yacoubi Loueslati B, Troudi W et al (2006) HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia? Pathol Oncol Res 12(2):79–81

    PubMed  Article  Google Scholar 

  31. Ferrera A, Olivo A, Alaez C et al (1999) HLA-DOA1 and -DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection. Hum Biol 71(3):367–379

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by Tehran University of Medical Sciences (grant No. 4785). The authors are very grateful to all colleagues in Molecular Immunology Research Center, Tehran University of Medical Sciences for their kind help and to all the patients for their kind collaboration in this study.

Author information

Authors and Affiliations

  1. Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Majid Mahmoodi, Hedayat Nahvi, Amir Kasaian, Mohammad-Ali Mohagheghi, Bijan Nahavandian & Abbas Jafari

  2. Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Mahdi Mahmoudi, Bita Ansarpour, Batoul Moradi & Aliakbar Amirzargar

  3. Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran

    Kouros Divsalar

  4. Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Asghar Aghamohammadi

  5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Aliakbar Amirzargar

Authors
  1. Majid Mahmoodi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hedayat Nahvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahdi Mahmoudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amir Kasaian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammad-Ali Mohagheghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kouros Divsalar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bijan Nahavandian
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Abbas Jafari
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bita Ansarpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Batoul Moradi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Asghar Aghamohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Aliakbar Amirzargar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aliakbar Amirzargar.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mahmoodi, M., Nahvi, H., Mahmoudi, M. et al. HLA-DRB1,-DQA1 and -DQB1 Allele and Haplotype Frequencies in Female Patients with Early Onset Breast Cancer. Pathol. Oncol. Res. 18, 49–55 (2012). https://doi.org/10.1007/s12253-011-9415-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-011-9415-6

Keywords

  • Allele frequency
  • Breast cancer
  • Human leukocyte antigen (HLA)
  • HLA-DRB1
  • -DQA1
  • -DQB1